Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
JTC
JEMTEC
C$1.10
C$1.25
C$0.71
C$1.60
C$3.08M0.2277743,013 shs110 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
JTC
JEMTEC
0.00%-6.78%-0.90%-29.49%+22.22%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
JTC
JEMTEC
C$1.10
C$1.25
C$0.71
C$1.60
C$3.08M0.2277743,013 shs110 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
JTC
JEMTEC
0.00%-6.78%-0.90%-29.49%+22.22%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
JTC
JEMTEC
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
JTC
JEMTEC
C$1.90M1.62C$0.61 per share1.80C$0.84 per share1.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A
JTC
JEMTEC
N/AC$0.0715.71N/AN/A2.74%1.87%2.06%N/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
JTC
JEMTEC
N/A7.14%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ATT
Abattis Bioceuticals
N/AN/AN/A
JTC
JEMTEC
0.40
11.95
14.45

Institutional Ownership

CompanyInstitutional Ownership
ATT
Abattis Bioceuticals
N/A
JTC
JEMTEC
18.25%

Insider Ownership

CompanyInsider Ownership
ATT
Abattis Bioceuticals
N/A
JTC
JEMTEC
50.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
JTC
JEMTEC
N/A2.80 millionN/ANot Optionable

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

JEMTEC CVE:JTC

C$1.10 0.00 (0.00%)
As of 05/5/2026 12:58 PM Eastern

JEMTEC Inc. provides integrated technology systems for community-based corrections in Canada. It offers services and technologies for offender monitoring in Canadian federal and provincial correctional departments. The company also provides various levels of technology, which allows corrections, courts, and police to select from various options ensuring the correct level of offender control. n addition, its offender location detection/verification technologies include offender reporting through telephone contact, offender reporting kiosks with integrated database, global positioning system active and passive tracking, voice verification, electronic monitoring house arrest systems, remote alcohol in-home monitoring, and private monitoring services. JEMTEC Inc. was incorporated in 1981 and is headquartered in North Vancouver, Canada.